← Evidence map

ReviewTopics in antiviral medicine

Beyond telaprevir and boceprevir: resistance and new agents for hepatitis C virus infection.

David L WylesPubMed ↗Full text ↗

No numbers read from the abstract.

16 papers cite it

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
trialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 23154254